SEELOS THERAPEUTICS
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare disorders. The Company's robust portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders, including orphan diseases.
SEELOS THERAPEUTICS
Industry:
Biotechnology Pharmaceutical
Founded:
1987-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.seelostherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
51.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics Font Awesome Wordpress Plugins
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Crinetics Pharmaceuticals
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Current Employees Featured
Founder
Stock Details
Investors List
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Seelos Therapeutics
The Lind Partners
The Lind Partners investment in Post-IPO Debt - Seelos Therapeutics
Official Site Inspections
http://www.seelostherapeutics.com Semrush global rank: 2.54 M Semrush visits lastest month: 6.93 K
- Host name: cloudproxy10160.sucuri.net
- IP address: 192.124.249.160
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Seelos Therapeutics"
Overview and Financials - Seelos Therapeutics
Stock Information Investor and Media Relations Anthony Marciano Chief Communications Officer Seelos Therapeutics, Inc. [email protected] Offices Seelos Therapeutics, Inc. …See details»
Seelos Therapeutics - Crunchbase Company Profile
Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics.See details»
driven company focused on achieving the most efficient …
Advancing multiple late-stage therapeutic candidates for CNS disorders Developing therapeutics with proven mechanisms of action Identifying opportunities in large marketsSee details»
Seelos Therapeutics Headquarters & Corporate Office
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical business dedicated ...See details»
Seelos Therapeutics, Inc. | LinkedIn
Seelos Therapeutics, Inc. is a clinical-stage bio-pharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the …See details»
Seelos Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Sep 19, 2024 www.seelostherapeutics.com. Public Company | 1987 | New York, United States | 10-50 | NASDAQ: SEEL | www.seelostherapeutics.com. Last update 19 Sep 2024. Overview. …See details»
Seelos Therapeutics - Org Chart, Teams, Culture & Jobs …
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) …See details»
Seelos Therapeutics Company Description - Stock Analysis
Dec 13, 2024 Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous …See details»
Seelos Therapeutics - Company Profile - Tracxn
Oct 22, 2024 Seelos Therapeutics - Developer of therapies for treating CNS disorders and rare diseases. Public Company. Raised funding over 4 rounds from 3 investors. Founded by Raj …See details»
Seelos Therapeutics, Inc. Overview | SignalHire Company Profile
Seelos Therapeutics, Inc. is a clinical-stage bio-pharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the …See details»
Seelos Therapeutics, Inc. - Dun & Bradstreet
Company Description: Seelos Therapeutics (formerly Apricus Biosciences) is focused on finding treatments for central nervous system disorders and rare diseases. It has a portfolio of about a …See details»
Seelos Therapeutics - Craft
Seelos Therapeutics has 3 employees across 2 locations and $2.2 m in annual revenue in FY 2023. See insights on Seelos Therapeutics including office locations, competitors, revenue, …See details»
Seelos Therapeutics Announces FDA Acceptance of Investigational …
Nov 8, 2021 NAF is a nonprofit organization established in 1957 to help persons with ataxia and their families. The Foundation's mission is to accelerate the development of treatments and a …See details»
Seelos Therapeutics - Overview, News & Similar companies
May 15, 2023 Seelos Therapeutics contact info: Phone number: (646) 293-2100 Website: www.seelostherapeutics.com What does Seelos Therapeutics do? Seelos Therapeutics, Inc. …See details»
Stock Information - Seelos Therapeutics
Investor and Media Relations Anthony Marciano Head of Corporate Communications Seelos Therapeutics, Inc. [email protected] Offices Seelos Therapeutics, Inc. 300 …See details»
How Does Seelos Therapeutics Work? - CBM
Website: seelostherapeutics.com; Description: Seelos Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and advancement of novel …See details»
Seelos Therapeutics Doses First Patients in an Ethnobridging Study …
NEW YORK, Feb. 6, 2023 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central …See details»
Seelos Therapeutics Announces FDA Acceptance of Investigational …
Nov 8, 2021 NAF is a nonprofit organization established in 1957 to help persons with ataxia and their families. The Foundation's mission is to accelerate the development of treatments and a …See details»